Share on Facebook
Share on Twitter
Share on LinkedIn
Share by Email
Print
Kyleena Generic Name & Formulations
Legal Class
Rx
General Description
Levonorgestrel 19.5mg; intrauterine system.
Pharmacological Class
Progestin IUD.
How Supplied
System—1
Manufacturer
Generic Availability
NO
Kyleena Indications
Indications
Prevention of pregnancy for up to 5yrs.
Kyleena Dosage and Administration
Adult
See full labeling. Insert into uterine cavity as directed. Reexamine and evaluate 4–6wks after insertion; then yearly or more if needed. Remove or replace after 5yrs.
Children
Pre-menarche: not recommended.
Kyleena Contraindications
Contraindications
Pregnancy. Post-coital contraception. Congenital or acquired uterine anomaly including fibroids. Acute or history of pelvic inflammatory disease (PID) unless there has been a subsequent intrauterine pregnancy. Postpartum endometritis or infected abortion in past 3 months. Uterine or cervical neoplasia. Breast or other progestin-sensitive cancer. Uterine bleeding of unknown etiology. Untreated acute cervicitis or vaginitis. Active liver disease or tumor. Conditions associated with increased susceptibility to pelvic infections. Retained IUD.
Kyleena Boxed Warnings
Not Applicable
Kyleena Warnings/Precautions
Warnings/Precautions
Evaluate for ectopic pregnancy. Risk of spontaneous abortion, miscarriage, sepsis, premature labor or delivery, congenital anomalies: remove if pregnant. Consider risks of PID before using. Remove if endometritis or PID recurs or if acute pelvic infection is severe or unresponsive to treatment. Bleeding pattern alterations: exclude endometrial pathology prior to insertion in women with persistent or uncharacteristic bleeding. Risk of perforation, expulsion and ovarian cysts. Increased risk of perforation in women recently given birth, who are breastfeeding, ≤6 weeks postpartum, if inserted in women with fixed retroverted or not completely involuted uteri. Consider removal if coagulopathy, migraine, transient cerebral ischemia, severe headache, marked increase in BP, severe arterial disease, uterine/cervical malignancy, jaundice, or symptomatic actinomycosis occurs. May be scanned with MRI under specific conditions. Nursing mothers.
Kyleena Pharmacokinetics
See Literature
Kyleena Interactions
Interactions
Caution with anticoagulants; consider removal. May be antagonized by CYP3A4 inducers. May be potentiated by CYP3A4 inhibitors.
Kyleena Adverse Reactions
Adverse Reactions
Vulvovaginitis, ovarian cyst, abdominal/pelvic pain, headache/migraine, acne/seborrhea, dysmenorrhea/uterine spasm, breast pain/breast discomfort, increased bleeding; ectopic pregnancy, intrauterine pregnancy, sepsis, PID, perforation, expulsion.
Kyleena Clinical Trials
See Literature
Kyleena Note
Not Applicable
Kyleena Patient Counseling
See Literature
Images
